Jupiter Neurosciences Ratios (2024-2025) | JUNS

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter) 2,470.84%1,089.56%559.60%-7,625.20%124,399.27%198,499.12%191,788.26%4,596.72%
EBIT Margin (Quarter) 2,215.77%989.66%459.62%-7,496.05%125,142.64%199,548.90%192,544.26%4,496.72%
EBITDA Margin (Quarter) 2,215.77%989.66%459.62%-7,496.05%125,142.64%199,548.90%192,544.26%4,496.72%
Operating Margin (Quarter) 2,215.77%989.66%459.62%-7,496.05%125,142.64%199,548.90%192,544.26%4,496.72%
Net Margin (Quarter) 2,470.84%1,089.56%559.60%-7,625.20%124,399.27%198,499.12%191,788.26%4,596.72%
FCF Margin (Quarter) 253.01%190.91%39.67%-18,996.55%86,496.42%72,971.10%96,768.65%3,791.08%
Efficiency
Assets Average (Quarter) 3.14M5.58M4.47M3.27M4.07M
Equity Average (Quarter) -5.69M-5.55M-0.79M3.62M2.20M0.70M-0.89M
Invested Capital (Quarter) -6.02M-5.36M-5.14M4.17M3.06M1.34M0.06M-1.83M
Asset Utilization Ratio (Quarter) -0.05-0.03-0.020.00-0.02
Leverage & Solvency
Interest Coverage Ratio (Quarter) -8.68-9.90-4.60-47.74-0.00M-0.00M-0.00M-44.97
Debt to Equity (Quarter) -0.11
Debt Ratio (Quarter) 7.09
Equity Ratio (Quarter) -67.230.670.620.340.02-0.33
Times Interest Earned (Quarter) -8.68-9.90-4.60-47.74-0.00M-0.00M-0.00M-44.97
Valuation
Enterprise Value (Quarter) -0.01M-0.01M-253.00-3.77M-2.71M-1.88M-0.72M-3.79M
Return Ratios
Return on Sales (Quarter) 24.71%10.90%5.60%-76.25%1,243.99%1,984.99%1,917.88%45.97%
Return on Capital Employed (Quarter) -2.71%-1.10%-3.13%-10.03%2.68%
Return on Assets (Quarter) -1.06%-0.76%-1.31%-2.31%-2.20%
Return on Equity (Quarter) 4.22%-1.17%-2.66%-10.81%10.08%